Literature DB >> 8898630

5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment].

D K Rex1, O W Cummings, D J Helper, T V Nowak, J M McGill, G Z Chiao, P Y Kwo, K T Gottlieb, S O Ikenberry, F G Gress, G A Lehman, L J Born.   

Abstract

BACKGROUND & AIMS: Cost-effectiveness of colorectal cancer screening will be maximized by selecting the widest screening intervals that effectively prevent cancer mortality. However, data on the incidence of neoplasia in persons with no abnormal findings on initial examination are limited. The aim of this study was to describe the incidence of colonic neoplasia 5 years after negative screening colonoscopy in asymptomatic average-risk persons.
METHODS: We previously reported the results of screening colonoscopy in 496 asymptomatic average-risk persons, 368 of whom had no neoplasia identified. Colonoscopy to the cecum was performed in 154 of these persons at a mean of 66 months after the initial negative colonoscopy.
RESULTS: Forty-one (27%) had at least one adenoma, but only 1 person had an adenoma > or = 1 cm and none had cancer, severe dysplasia, or villous or tubulovillous histology. Hyperplastic polyps at the initial examination did not predict incident adenomas. Regular nonsteroidal anti-inflammatory drug use was associated with a decreased rate of incident adenomas.
CONCLUSIONS: In average-risk persons, the interval between screening examinations can be safely expanded beyond 5 years, provided the initial examination is a carefully performed complete colonoscopy that is negative for colonic adenomas or cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8898630     DOI: 10.1053/gast.1996.v111.pm8898630

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Metaplastic (hyperplastic) polyps of the large bowel: benign neoplasms after all?

Authors:  G T Williams
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; Philip S Schoenfeld; Jonathan Cohen; Irving M Pike; Douglas G Adler; M Brian Fennerty; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Sachin Wani; David S Weinberg
Journal:  Am J Gastroenterol       Date:  2014-12-02       Impact factor: 10.864

Review 3.  [Early diagnosis of colorectal tumors].

Authors:  C Lamberti; T Sauerbruch
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

4.  Five year colorectal cancer outcomes in a large negative CT colonography screening cohort.

Authors:  David H Kim; B Dustin Pooler; Jennifer M Weiss; Perry J Pickhardt
Journal:  Eur Radiol       Date:  2011-12-31       Impact factor: 5.315

5.  Colonoscopy surveillance after polypectomy.

Authors:  Kunio Kasugai; Naotaka Ogasawara; Makoto Sasaki
Journal:  Clin J Gastroenterol       Date:  2011-10-16

Review 6.  [Choosing wisely recommendations in gastroenterology].

Authors:  H Koop; P Lynen Jansen; S Zeuzem
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

7.  Assessing the effectiveness of a cancer screening test in the presence of another screening modality.

Authors:  Jessica Chubak; Rebecca A Hubbard; Eric Johnson; Aruna Kamineni; Carolyn M Rutter
Journal:  J Med Screen       Date:  2014-12-09       Impact factor: 2.136

8.  Quality indicators for colorectal cancer screening for colonoscopy.

Authors:  Philip S Schoenfeld; Jonathan Cohen
Journal:  Tech Gastrointest Endosc       Date:  2013-04

9.  A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2.

Authors:  Georgia L Wiesner; Denise Daley; Susan Lewis; Christine Ticknor; Petra Platzer; James Lutterbaugh; Melissa MacMillen; Boris Baliner; Joseph Willis; Robert C Elston; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

10.  Screening techniques for prevention and early detection of colorectal cancer in the average-risk population.

Authors:  Hana Strul; Nadir Arber
Journal:  Gastrointest Cancer Res       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.